Cargando…
High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration
PURPOSE: To elucidate the clinical and prognostic role of PDZ and LIM domain protein (PDLIM) genes and the association to epithelial-mesenchymal transition (EMT) and immune cell infiltration in patients with prostate cancer (PRAD). METHODS: The data of RNA-seq, DNA methylation, and clinical features...
Autores principales: | Piao, Songzhe, Zheng, Lan, Zheng, Haihong, Zhou, Mengya, Feng, Qin, Zhou, Suna, Ke, Mang, Yang, Haihua, Wang, Xuequan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192325/ https://www.ncbi.nlm.nih.gov/pubmed/35707002 http://dx.doi.org/10.1155/2022/2922832 |
Ejemplares similares
-
Increased ATG5 Expression Predicts Poor Prognosis and Promotes EMT in Cervical Carcinoma
por: Zhou, Suna, et al.
Publicado: (2021) -
Corrigendum: Increased ATG5 Expression Predicts Poor Prognosis and Promotes EMT in Cervical Carcinoma
por: Zhou, Suna, et al.
Publicado: (2022) -
PDLIM2 regulates transcription factor activity in epithelial-to-mesenchymal transition via the COP9 signalosome
por: Bowe, Rachael A., et al.
Publicado: (2014) -
Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma
por: Wang, Xuequan, et al.
Publicado: (2021) -
Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis
por: Liu, Long, et al.
Publicado: (2023)